Growth Hormone vs. GHRH: Why Peptides are Safer than HGH - 120

Is your coach telling you to inject an HIV drug to lose belly fat? They might be right, but they shouldn't be the one prescribing it. In our second "Provider Science" segment on Beyond The Pump, we welcome back Dr. Trevor Turner (MD, PM&R) to do a deep dive into Tesamorelin, one of the most popular Growth Hormone Releasing Hormones (GHRH) on the market. Originally commercialized as Egrifta for the HIV population to manage lipodystrophy, Tesamorelin is now widely used to improve beta-oxidation and reduce dangerous visceral adipose tissue (belly fat) in the general population. But before you buy a vial online, Dr. Turner explains the biological "machinery" behind it, why it's safer than exogenous HGH, and the side effects (like swollen joints and carpal tunnel) that occur when amateurs push their IGF-1 levels too high. Listen now to understand the cellular biology of fat loss and why you need a doctor, not a "gym bro," to manage your peptides. Follow us for more:  YouTube: https://www.youtube.com/@OfficialBeyondThePump Instagram: @officialbeyondthepump  Facebook: https://www.facebook.com/share/g/B2uM6Fv5NWhdKbhq/